Form D · Biotechnology

Mnemosyne Pharmaceuticals Inc

Providence, RI · CIK 0001542171

Offering snapshot reported Feb 4, 2015 · SEC filing

Reported sold
$12.3M
Offering amount: $13M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 1, 2012
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$6.17M$12.3MFeb 16, 2012: $3,234,496.00Feb 16, 2012Feb 1, 2013: $3,234,496.00Feb 1, 2013Jul 3, 2013: $8,384,496.00Feb 4, 2015: $12,332,334.00Feb 4, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$3,234,496 → $12,332,334
  • Reported investors4 → 6

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 4, 2015Amendment$12,332,334$9,097,838vs Feb 1, 20136SEC filing
Jul 3, 2013Amendment$8,384,496$5,150,000vs Feb 16, 20126SEC filing
Feb 1, 2013Amendment$3,234,496$0vs Feb 16, 20124SEC filing
Feb 16, 2012Initial$3,234,496No comparison4SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-173595
Series A Convertible Preferred Stock

Source: Form D, filed Feb 4, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jessica Barnes Director
Peter Barrett Director
Daniel Behr Director
James Bristol Director
Benjamin Bronstein Director
Jared Fertman Director
Richard Horan Director
Vanessa King Director, Executive
William Koster Director
Frank Menniti Executive
Kollol Pal Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
Three Davol Square Suite A425
Providence, RI, 02903